1
Fontan modification with a Y-graft Aditya K. Kaza, MD The well-written article by Hunt Martin and colleagues 1 in this issue of the Journal describes a single-institution expe- rience with the Y-graft modification for Fontan completion. The cavopulmonary connection has evolved significantly since it was first described by Fontan and coworkers. 2 In this particular case, Martin and colleagues aim to translate the superior hemodynamic and hepatic blood flow distribu- tion seen in computational modeling with the use of bifur- cated Fontan grafts. 3 The fundamental premise for using this type of Fontan modification is that this type of arrange- ment is superior to the pure energy conservation afforded by offsetting the Glenn and Fontan flows. These benefits are still theoretic, and there is no demonstration in the article that the computer modeling scenario was duplicated in the clinical outcomes of these children. Martin and colleagues, however, have been able to demonstrate technical feasi- bility of using these bifurcated grafts with excellent safety and hemodynamic results. This is an extremely important area of investigation to optimize hemodynamics and flow distributions in patients undergoing completion Fontan operations. Other groups 4 have also used computational modeling to tout the beneficial effects of bifurcated Glenn and Fontan pathways or the ‘‘optiflow’’ configuration. Two of the authors of this article have published previous work 3 related to the computational modeling and preclini- cal evaluation, examining the impact of this Fontan modifi- cation on hepatic blood flow distribution. They have successfully shown that in the modeling scenario, there is more symmetric hepatic blood flow distribution. This article shows the nice systematic evolution of this theoretic concept to clinical translation. They have now shown the clinical feasibility of this modified cavopulmonary connec- tion. There are some concerning outcomes which need to be rectified before widespread recommendation or use, espe- cially the avoidance of thrombus formation in one of the limbs. In addition, there needs to be long-term follow up with quantification of arteriovenous malformation in the pulmonary vasculature and general clinical outcomes and the presence or absence of other signs of Fontan failure, such as plastic bronchitis or protein-losing enteropathy. Another potential benefit of this bifurcated graft technique is to customize the diameter of limbs (and as a result, flow) to each lung according to the degree of arteriovenous malformation noted on pre-Fontan studies. Long-term flow and hemodynamic data would further convince clinicians to adopt this Fontan modification technique. The results of this early experience with this Y-graft Fontan modification are encouraging, and it is to hoped that Martin and colleagues will publish more follow-up data to determine whether there are any hemodynamic and functional advantages related to this modification. References 1. Hunt Martin M, Feinstein JA, Chan FP, Marsden AL, Yang W, Mohan Reddy VM. Technical feasibility and intermediate outcomes of using a handcrafted, area- preserving, bifurcated Y-graft modification of the Fontan procedure. J Thorac Cardiovasc Surg. 2014. In press. 2. Fontan F, Mounicot FB, Baudet E, Simonneau J, Gordo J, Gouffrant JM. [‘‘Correc- tion’’ of tricuspid atresia. 2 cases ‘‘corrected’’ using a new surgical technic]. Ann Chir Thorac Cardiovasc. 1972;10:39-47. French. 3. Yang W, Feinstein JA, Shadden SC, Vignon-Clemntel IE, Marsden AL. Optimization of a Y-graft design for improved hepatic flow distribution in the Fontan circulation. J Biomech Eng. 2013;135:011002. 4. Slesnick TC, Yoganathan AP. Computational modeling of Fontan physiology: at the crossroads of pediatric cardiology and biomedical engineering. Int J Cardiovasc Imaging. 2014;30:1073-84. See related article on pages xxxx-x. From the Department of Cardiac Surgery, Boston Children’s Hospital, Boston, Mass. Disclosures: The author has nothing to disclose with regard to commercial support. Received for publication Sept 11, 2014; accepted for publication Sept 11, 2014. Address for reprints: Aditya K. Kaza, MD, Department of Cardiac Surgery, Boston Children’s Hospital, 300 Longwood Ave, Bader 273, Boston, MA 02115 (E-mail: [email protected]). J Thorac Cardiovasc Surg 2014;-:1 0022-5223/$36.00 Copyright Ó 2014 by The American Association for Thoracic Surgery http://dx.doi.org/10.1016/j.jtcvs.2014.09.015 The Journal of Thoracic and Cardiovascular Surgery c Volume -, Number - 1 EDITORIAL COMMENTARY

Fontan modification with a Y-graft

Embed Size (px)

Citation preview

Page 1: Fontan modification with a Y-graft

EDITORIAL COMMENTARY

Fontan modification with a Y-graft

Aditya K. Kaza, MD

See related article on pages xxxx-x.

The well-written article by Hunt Martin and colleagues1 inthis issue of the Journal describes a single-institution expe-rience with the Y-graft modification for Fontan completion.The cavopulmonary connection has evolved significantlysince it was first described by Fontan and coworkers.2 Inthis particular case, Martin and colleagues aim to translatethe superior hemodynamic and hepatic blood flow distribu-tion seen in computational modeling with the use of bifur-cated Fontan grafts.3 The fundamental premise for usingthis type of Fontan modification is that this type of arrange-ment is superior to the pure energy conservation afforded byoffsetting the Glenn and Fontan flows. These benefits arestill theoretic, and there is no demonstration in the articlethat the computer modeling scenario was duplicated in theclinical outcomes of these children. Martin and colleagues,however, have been able to demonstrate technical feasi-bility of using these bifurcated grafts with excellent safetyand hemodynamic results. This is an extremely importantarea of investigation to optimize hemodynamics and flowdistributions in patients undergoing completion Fontanoperations. Other groups4 have also used computationalmodeling to tout the beneficial effects of bifurcated Glennand Fontan pathways or the ‘‘optiflow’’ configuration.

Two of the authors of this article have published previouswork3 related to the computational modeling and preclini-cal evaluation, examining the impact of this Fontan modifi-cation on hepatic blood flow distribution. They havesuccessfully shown that in the modeling scenario, there ismore symmetric hepatic blood flow distribution. Thisarticle shows the nice systematic evolution of this theoretic

From the Department of Cardiac Surgery, Boston Children’s Hospital, Boston, Mass.

Disclosures: The author has nothing to disclose with regard to commercial support.

Received for publication Sept 11, 2014; accepted for publication Sept 11, 2014.

Address for reprints: Aditya K. Kaza, MD, Department of Cardiac Surgery, Boston

Children’s Hospital, 300 Longwood Ave, Bader 273, Boston, MA 02115

(E-mail: [email protected]).

J Thorac Cardiovasc Surg 2014;-:1

0022-5223/$36.00

Copyright � 2014 by The American Association for Thoracic Surgery

http://dx.doi.org/10.1016/j.jtcvs.2014.09.015

The Journal of Thoracic and C

concept to clinical translation. They have now shown theclinical feasibility of this modified cavopulmonary connec-tion. There are some concerning outcomes which need to berectified before widespread recommendation or use, espe-cially the avoidance of thrombus formation in one of thelimbs. In addition, there needs to be long-term follow upwith quantification of arteriovenous malformation in thepulmonary vasculature and general clinical outcomes andthe presence or absence of other signs of Fontan failure,such as plastic bronchitis or protein-losing enteropathy.Another potential benefit of this bifurcated graft techniqueis to customize the diameter of limbs (and as a result,flow) to each lung according to the degree of arteriovenousmalformation noted on pre-Fontan studies. Long-term flowand hemodynamic data would further convince clinicians toadopt this Fontan modification technique. The results of thisearly experience with this Y-graft Fontan modification areencouraging, and it is to hoped that Martin and colleagueswill publish more follow-up data to determinewhether thereare any hemodynamic and functional advantages related tothis modification.

References1. HuntMartinM, Feinstein JA, Chan FP,Marsden AL, YangW,Mohan Reddy VM.

Technical feasibility and intermediate outcomes of using a handcrafted, area-

preserving, bifurcated Y-graft modification of the Fontan procedure. J Thorac

Cardiovasc Surg. 2014. In press.

2. Fontan F,Mounicot FB, Baudet E, Simonneau J, Gordo J, Gouffrant JM. [‘‘Correc-

tion’’ of tricuspid atresia. 2 cases ‘‘corrected’’ using a new surgical technic]. Ann

Chir Thorac Cardiovasc. 1972;10:39-47. French.

3. YangW, Feinstein JA, Shadden SC,Vignon-Clemntel IE,MarsdenAL.Optimization

of a Y-graft design for improved hepatic flow distribution in the Fontan circulation.

J Biomech Eng. 2013;135:011002.

4. Slesnick TC, Yoganathan AP. Computational modeling of Fontan physiology: at the

crossroads of pediatric cardiology and biomedical engineering. Int J Cardiovasc

Imaging. 2014;30:1073-84.

ardiovascular Surgery c Volume -, Number - 1